Partha M Das

Summary

Publications

  1. ncbi Methylation mediated silencing of TMS1/ASC gene in prostate cancer
    Partha M Das
    Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA
    Mol Cancer 5:28. 2006
  2. ncbi Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk
    Rakesh Singal
    Division of Hematology Oncology, University of Miami Sylvester Comprehensive Cancer Center, 1475 NW 12th Avenue D8 4, Suite 3300, Miami, FL 33136, USA
    Oncol Rep 14:569-73. 2005
  3. ncbi Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk
    Rakesh Singal
    Division of Hematology Oncology, University of Miami Sylvester Comprehensive Cancer Center, 1475 NW 12th Avenue D8 4, Ste 3300, Miami, FL 33136, USA
    Int J Oncol 25:1465-71. 2004
  4. ncbi Chromatin immunoprecipitation assay
    Partha M Das
    University of Miami School of Medicine, Miami, FL 33136, USA
    Biotechniques 37:961-9. 2004
  5. ncbi DNA methylation and cancer
    Partha M Das
    Department of Medicine, Miami VA Medical Center, Miami, FL, USA
    J Clin Oncol 22:4632-42. 2004

Detail Information

Publications5

  1. ncbi Methylation mediated silencing of TMS1/ASC gene in prostate cancer
    Partha M Das
    Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA
    Mol Cancer 5:28. 2006
    ..We also examined the prevalence of TMS1/ASC gene methylation in prostate cancer tissue samples in an effort to correlate race and clinico-pathological features with TMS1/ASC gene methylation...
  2. ncbi Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk
    Rakesh Singal
    Division of Hematology Oncology, University of Miami Sylvester Comprehensive Cancer Center, 1475 NW 12th Avenue D8 4, Suite 3300, Miami, FL 33136, USA
    Oncol Rep 14:569-73. 2005
    ..These findings suggest that the DNMT3b polymorphisms may be associated with an increase in promoter methylation of tumor-suppressor genes related to the development of prostate cancer, and may thereby increase the risk of this disease...
  3. ncbi Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk
    Rakesh Singal
    Division of Hematology Oncology, University of Miami Sylvester Comprehensive Cancer Center, 1475 NW 12th Avenue D8 4, Ste 3300, Miami, FL 33136, USA
    Int J Oncol 25:1465-71. 2004
    ..0-0.7) and earlier stage disease (aOR=0.3 for stage III versus II, 95% CI: 0.3-2.6). These findings suggest that polymorphisms of the MTHFR gene may alter the risk of developing prostate cancer...
  4. ncbi Chromatin immunoprecipitation assay
    Partha M Das
    University of Miami School of Medicine, Miami, FL 33136, USA
    Biotechniques 37:961-9. 2004
    ..This review addresses the critical parameters and the variants of ChiP as well as the different analytical tools that can be combined with ChIP to enable better understanding of DNA-protein interactions in vivo...
  5. ncbi DNA methylation and cancer
    Partha M Das
    Department of Medicine, Miami VA Medical Center, Miami, FL, USA
    J Clin Oncol 22:4632-42. 2004
    ..Novel demethylating agents such as antisense DNA methyl transferase and small interference RNA are being developed, making the field of DNA methylation wider and more exciting...